These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21205400)

  • 1. The generic drug market in Japan: will it finally take off?
    Iizuka T; Kubo K
    Health Econ Policy Law; 2011 Jul; 6(3):369-89. PubMed ID: 21205400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition between brand-name and generics--analysis on pricing of brand-name pharmaceutical.
    Kong Y
    Health Econ; 2009 May; 18(5):591-606. PubMed ID: 18816580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of French generic medicines retail market: why the use of generic medicines is limited.
    Dylst P; Vulto A; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2014 Dec; 14(6):795-803. PubMed ID: 25095903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Regresses for medicine prescription: benchmark evaluations should be eliminated].
    Dryden WA
    MMW Fortschr Med; 2013 Nov; 155 Spec No 2():16. PubMed ID: 24734441
    [No Abstract]   [Full Text] [Related]  

  • 6. Choice of generic versus brand-name antidepressants in a regulated prescription drug market: evidence from Taiwan.
    Liu YM; Ou HT; Yang YK
    J Ment Health Policy Econ; 2014 Dec; 17(4):163-72. PubMed ID: 25599280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of cost sharing on prescription drugs used by Medicare beneficiaries.
    Goedken AM; Urmie JM; Farris KB; Doucette WR
    Res Social Adm Pharm; 2010 Jun; 6(2):100-9. PubMed ID: 20511109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determinants of branded prescription medicine prices in OECD countries.
    Kanavos PG; Vandoros S
    Health Econ Policy Law; 2011 Jul; 6(3):337-67. PubMed ID: 21676345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indonesian doctors are told to prescribe generics to reduce health costs.
    Bland B
    BMJ; 2010 Jan; 340():c349. PubMed ID: 20089590
    [No Abstract]   [Full Text] [Related]  

  • 10. Demand-side policies to encourage the use of generic medicines: an overview.
    Dylst P; Vulto A; Simoens S
    Expert Rev Pharmacoecon Outcomes Res; 2013 Feb; 13(1):59-72. PubMed ID: 23402447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imperative to consider multiple initiatives to maximize prescribing efficiency from generic availability: case history from Abu Dhabi.
    Abuelkhair M; Abdu S; Godman B; Fahmy S; Malmström RE; Gustafsson LL
    Expert Rev Pharmacoecon Outcomes Res; 2012 Feb; 12(1):115-24. PubMed ID: 22280201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contemporary generic market in Japan - key conditions to successful evolution.
    Jakovljevic MB; Nakazono S; Ogura S
    Expert Rev Pharmacoecon Outcomes Res; 2014 Apr; 14(2):181-94. PubMed ID: 24450984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of generic competition on the price of brand-name drugs.
    Lexchin J
    Health Policy; 2004 Apr; 68(1):47-54. PubMed ID: 15033552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of introducing inpatient mandatory generic drug substitution at Ramathobodi Hospital.
    Kaojarern S; Pattanaprateep O
    J Med Assoc Thai; 2012 Apr; 95(4):519-25. PubMed ID: 22612005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors associated with independent pharmacy owners' satisfaction with Medicare Part D contracts.
    Zhang S; Doucette WR; Urmie JM; Xie Y; Brooks JM
    Res Social Adm Pharm; 2010 Jun; 6(2):121-9. PubMed ID: 20511111
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generic medications for you, but brand-name medications for me.
    Keenum AJ; Devoe JE; Chisolm DJ; Wallace LS
    Res Social Adm Pharm; 2012; 8(6):574-8. PubMed ID: 22357268
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generics: what's in a name?
    Keith LG; Oleszczuk JJ; Stika CS; Stine S
    Int J Fertil Womens Med; 1998; 43(3):139-49. PubMed ID: 9692536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Policies to promote use of generic medicines in low and middle income countries: a review of published literature, 2000-2010.
    Kaplan WA; Ritz LS; Vitello M; Wirtz VJ
    Health Policy; 2012 Aug; 106(3):211-24. PubMed ID: 22694970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategic options for brand-name prescription drugs when patents expire.
    Mehta SC; Mehta SS
    Health Mark Q; 1997; 14(3):107-14. PubMed ID: 10167309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Generic substitution in primary care in 2011: differences according to pharmacological classes?].
    Sommet A; Georgel B; Poutrain JC; Oustric S; Bourrel R; Montastruc JL; Birebent J
    Rev Epidemiol Sante Publique; 2013 Dec; 61(6):539-44. PubMed ID: 24211149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.